Pathway · 14 listed providers
Bariatric surgery vs GLP-1 medication — Australian guide + provider directory
The two effective options for adults with BMI 30+ in Australia who have not achieved sustained weight loss through diet + exercise alone. **Bariatric surgery** (sleeve gastrectomy or gastric bypass): permanent, 25–30% body weight loss, $8–25k cost. **GLP-1 medication** (Wegovy or Mounjaro): ongoing weekly injection, 15–21% body weight loss while medication continues, $5–7k/year. The right choice depends on BMI, comorbidities, age, lifestyle and willingness to commit to a permanent procedure versus an ongoing treatment.
★Key takeaways
- ✓14 verified Australian providers offering bariatric surgery vs glp-1 medication — ranked by ANZMOSS membership + years in practice.
- ✓You've tried medical weight loss without sustained success, your BMI is 30+ with weight-related health conditions OR BMI 40+, and you're considering either surgical or medical pathways. The two are not mutually exclusive — many patients use GLP-1 first, then transition to surgery if response is insufficient, or use GLP-1 pre-operatively to optimise surgical safety.
- ✓Decision-relevant cost framing: bariatric surgery $8–25k once-off (with private health insurance, $8–18k typical out-of-pocket). GLP-1 medication $5–7k per year indefinitely.
- ✓Source: AHPRA Specialist Register + ANZMOSS member directory + TGA-approved prescriber networks.
In depth
Everything you need to know about bariatric surgery vs glp-1 medication
**Effectiveness.** Surgery wins at the highest BMIs (45+) where the absolute kg loss matters and metabolic change is most needed. GLP-1 medications now produce 15–21% body weight loss — comparable to surgery at the lower BMI ranges (30–40) over the medication-active period. Five-year sustained outcomes still favour surgery for most patients with BMI 35+ at start.
**Permanence.** Surgery is permanent — the changed anatomy continues to suppress appetite + restrict intake indefinitely. Weight regain is possible (about 15–25% of patients regain significantly at 5 years) but the metabolic + appetite changes persist. GLP-1 medications work while you take them; stopping causes ~50–60% weight regain within 12 months. This makes GLP-1 a long-term commitment, not a course.
**Cost over time.** Sleeve gastrectomy with private health insurance: $8,000–$18,000 once-off. GLP-1 medication: $5,000–$7,000 per year, indefinitely. Break-even at year 3–4 — surgery becomes cheaper than continued GLP-1 from year 4 onward. Note that not all GLP-1 patients continue indefinitely; some sustain weight loss with diet/exercise after a 18–24 month medication course.
**Diabetes + comorbidities.** Bariatric surgery (especially Roux-en-Y bypass) produces stronger Type 2 diabetes remission rates than GLP-1 medications — about 60–70% remission off all medication at 12 months for surgery vs ~25% for GLP-1. Surgery also more strongly improves sleep apnoea, joint pressure, fatty liver disease. For patients whose primary clinical concern is diabetes or severe comorbidity, surgery is often the recommended path.
**Process + commitment.** Surgery: 3–6 month pre-op pathway (multidisciplinary assessment, mandatory dietitian + psychologist, pre-op diet) → operation → 6 weeks recovery → lifelong daily multivitamin + annual bloods. GLP-1: prescriber consultation → weekly injection → 3–4 month dose titration → indefinite continuation if desired. Surgery is a bigger one-time decision; GLP-1 is a lower-friction ongoing commitment.
**The combined approach.** Increasingly common: GLP-1 medication used pre-operatively (often 6–12 months) to reduce BMI before bariatric surgery, improving operative safety + outcomes. Also used post-operatively for patients with significant weight regain at 3–5 years post-surgery. Many bariatric clinics now offer both pathways.
Key facts
- Bariatric: permanent, 25-30% body weight loss at 12-24 months
- GLP-1: ongoing while medication continues, 15-21% body weight loss
- Bariatric: $8-25k once-off (with health fund), break-even vs GLP-1 at year 3-4
- GLP-1: $5-7k/year indefinitely
- Surgery: stronger diabetes remission, joint disease improvement
- GLP-1: lower-friction, no anaesthetic risk, reversible
- Combined approach common: GLP-1 pre-op then surgery
- BMI 45+: surgery generally recommended
- BMI 30-40 + early diabetes: GLP-1 first-line typical
Consider this pathway if
You've tried medical weight loss without sustained success, your BMI is 30+ with weight-related health conditions OR BMI 40+, and you're considering either surgical or medical pathways. The two are not mutually exclusive — many patients use GLP-1 first, then transition to surgery if response is insufficient, or use GLP-1 pre-operatively to optimise surgical safety.
Cost
Decision-relevant cost framing: bariatric surgery $8–25k once-off (with private health insurance, $8–18k typical out-of-pocket). GLP-1 medication $5–7k per year indefinitely. Break-even crossover at year 3–4 — surgery becomes cheaper from year 4 onward IF you would otherwise continue GLP-1 indefinitely. Most GLP-1 patients DO continue long-term because stopping causes significant weight regain. Includes also: pre-op multidisciplinary team ($1,500–$2,500 dietitian + psychologist + endocrinologist before either pathway), annual bloods + multivitamin (~$200/year both pathways), revision surgery probability (5–10% of bariatric patients within 10 years).
Directory · ANZMOSS + years
14 verified Australian providers offering bariatric surgery vs glp-1 medication
ANZMOSS members + FRACS-trained surgeons first, then sorted by years in practice. Every entry AHPRA-listed.
Melbourne · Richmond
ANZMOSSEpworth Centre for Bariatric Surgery
Dr Harry FrydenbergMBBS, FRACS (General Surgery)
Established in 1998, this is one of Australia's longest-running dedicated bariatric units, founded by Dr Frydenberg, a 3…
Sydney · Bella Vista
ANZMOSSCircle of Care
Dr Roy BrancatisanoMBBS, FRACS (Upper GI / Bariatric)
Multidisciplinary team led by Upper GI surgeon Dr Brancatisano with in-house bariatric dietitian, psychologist and nurse…
Melbourne · Bulleen
ANZMOSSDarebin Weight Loss Surgery
A/Prof Ahmad AlyMBBS, MS, FRACS
Led by A/Prof Ahmad Aly, Head of Upper GI Surgery at Austin Hospital and Clinical Associate Professor at Melbourne Unive…
Sydney · St Leonards
ANZMOSSDr Garett Smith - North Shore Upper GI & Bariatric
A/Prof Garett SmithBMed, MS, FRACS
Clinical Associate Professor at University of Sydney and supervisor of the Royal North Shore Bariatric Fellowship - the …
Melbourne · East Melbourne
ANZMOSSMelbourne Gastro Oesophageal Surgery
A/Prof Michael HiiMBBS, MS, FRACS
Three-surgeon practice (Hii, Ward, Winter) anchored at St Vincent's Hospital where A/Prof Hii is Deputy Director of the …
Brisbane · Sunnybank
ANZMOSSMastakov Surgery
Dr Mikhail MastakovMBBS, FRACS (General/Bariatric)
Operates across four hospitals from Brisbane to Hervey Bay with a dedicated in-house APD dietitian, exercise physiologis…
Perth · Subiaco
ANZMOSSPerth Surgical & Bariatrics
Dr Ravi RaoMBBS, FRACS (General/Bariatric)
One of only a handful of WA surgeons offering the SIPS/SADI-S procedure - a single-anastomosis duodenal switch alternati…
Sydney · Westmead
ANZMOSSSydney Bariatric Clinic
Dr Brendan RyanMBBS, FRACS (General Surgery)
Lead surgeon Dr Brendan Ryan has personally performed over 5,000 weight-loss operations, making this one of the highest-…
Perth · Joondalup
ANZMOSSPerth Bariatric Surgery
Dr Andrew KiyingiMBBS, FRACS (General/Bariatric)
The principal bariatric service for Perth's northern corridor - covers gastric band removal, revision and emergency bari…
Brisbane · Spring Hill
ANZMOSSBariatric Surgery Brisbane
Dr Chung WonMBBS, FRACS (General/Upper GI)
Senior Lecturer at the University of Queensland - operates across both private and public Brisbane hospitals giving unin…
Adelaide · Norwood
ANZMOSSAdelaide Bariatric Centre
Dr Tiffany HassenMBBS, FRACS (General/Bariatric)
Dr Hassen completed sub-specialty bariatric training at St George Hospital Sydney - the highest-volume bariatric unit in…
Sydney · Surry Hills
Juniper
Dr Matthew VickersMBBS, BMedSci, FRACGP (Specialist GP)
Sydney-headquartered Eucalyptus Health brand serving women nationally - now Australia's largest GLP-1 telehealth weight-…
Brisbane · Fortitude Valley
Pilot
Dr Matthew VickersMBBS, BMedSci, FRACGP (Specialist GP)
Sydney-founded Eucalyptus Health men's brand serving Australia nationally - the largest male-focused GLP-1 weight-loss t…
Adelaide · Adelaide CBD
Mosh
Mosh Medical TeamAHPRA-registered GPs
Independent Australian-founded telehealth provider serving patients nationally - combines GLP-1 medication, meal-replace…
Common questions
Bariatric surgery vs GLP-1 medication — common questions
Which is more effective?
Both highly effective. Surgery produces slightly higher weight loss in trials (25-30% body weight) than GLP-1 (15-21%), but the gap has narrowed dramatically with Mounjaro. For BMI 45+, surgery is generally more effective at the absolute kg level. For BMI 30-40, the two are comparable in the short to medium term. Long-term (5+ years) sustained outcomes still favour surgery for most patients with comorbidities.
I have Type 2 diabetes — which is better for me?
Bariatric surgery has stronger diabetes-remission outcomes than GLP-1. Roux-en-Y gastric bypass produces remission (off all diabetes medication) in 60-70% of patients with diabetes lasting under 10 years. Sleeve gastrectomy: 50-60% remission rate. GLP-1 medications produce remission in roughly 25% (mostly for diabetes lasting under 5 years on oral medications only). If diabetes is your primary concern, surgery is usually the recommended path.
Can I do both?
Yes, and increasingly common. Use GLP-1 medication for 6-12 months to reduce BMI before bariatric surgery (improves operative safety + outcomes). Or use GLP-1 post-surgery if significant weight regain occurs at 3-5 years post-op. Many bariatric clinics now offer integrated pathways. Discuss with your surgeon + GP — both can be combined under medical supervision.
What's the risk profile?
Surgery: 2-6% early complication rate (sleeve 2-4%, bypass 4-6%), mortality 0.1-0.2%. 5-10% lifetime revision surgery probability. Lifelong vitamin deficiency risk (managed with daily multivitamin + annual bloods). GLP-1: gastrointestinal side effects (40% nausea during titration, typically resolves), rare pancreatitis (<1%), gallbladder disease, animal studies showed thyroid C-cell tumours (no human signal). Both pathways are safe in mainstream Australian medical practice with appropriate selection + monitoring.
If I'm unsure, what's the safest starting point?
GLP-1 medication is the lower-friction starting point: weekly injection, no anaesthetic risk, fully reversible. If response is excellent (10%+ body weight loss in 6 months) and sustained, continue. If response is poor or you can't tolerate the medication, surgery is the next step. Many patients now follow this pathway. Discuss with prescriber + GP.